Though, there are important arguments against this idea
Historically, state Medicaid programs, state employee health plans and a myriad of other insurers have provided coverage of GLP-1s to treat Type 2 Diabetes
Anna Ferrulli, Department of Biomedical Sciences for Health, University of Milan, Milan 20133, Italy
Back Laughton, NB, Macallum, AB (1 June 1932) 'The Relation of duodenal mucosa to internal secretion of the pancreas', Proceedings of the Royal Society of London
Weight Loss: Average weight loss in the LEAD trials was 2 kg to 3.24 kg, with the majority of the reduction noted in the first 4 months of therapy, but tending to be sustained throughout the remaining period of the studies
Exenatide: pharmacokinetics, clinical use, and future directions